Top gainers, losers, and the catalysts behind the move
Start with the names driving price and volume, then decide which ones deserve a deeper look across screens, comparison, or valuation.
| # | Symbol | Price | Change | Volume | Mkt Cap | Driver | AI Insight |
|---|---|---|---|---|---|---|---|
| 1 | $8.09 | +863.10% | 249K | $7.0B | — | — | |
| 2 | $28.50 | +58.36% | 2.2M | $1.5B | — | — | |
| 3 | $8.80 | +25.79% | 72K | $930.7M | — | — | |
| 4 | $46.66 | +23.83% | 5.4M | $4.8B | — | — | |
| 5 | $1.42 | +23.48% | 19.6M | $2.2B | — | — | |
| 6 | $3.21 | +23.27% | 12.8M | $407.9M | — | — | |
| 7 | $1.40 | +21.30% | 10.7M | $277.5M | — | — | |
| 8 | $1.76 | +18.12% | 2.2M | $273.7M | — | — | |
| 9 | $4.31 | +17.76% | 329K | $149.0M | — | — | |
| 10 | $3.52 | +15.41% | 270K | $263.1M | — | — | |
| 11 | $6.09 | +15.34% | 7.3M | $173.0M | — | — | |
| 12 | $8.51 | +14.30% | 686K | $222.0M | — | — | |
| 13 | $4.83 | +13.92% | 97K | $342.1M | — | — | |
| 14 | $1.18 | +12.98% | 6.8M | $1.6B | — | — | |
| 15 | $3.46 | +12.87% | 991K | $311.6M | — | — |
Fresh analysis from the VCP Scanner news pipeline
Freshly published articles covering earnings, market movers, and company-specific setups tied to the same tickers you can research across the site.
AMD: Zuckerberg's AI Agent Vision, Baird's $1,250 Target, and the Margin Question
AMD is at the center of the AI infrastructure buildout, but flat gross margins and a post-earnings selloff raise questions about how much upside is left.
JNJ Hits 52-Week High Territory: Can a $629B Healthcare Giant Justify Its 30x Trailing P/E?
With blockbuster drug sales and a pending spinoff, J&J is firing on all cylinders — but valuation and insider selling give us pause.
Home Depot's Q2 Report Looms: Can a 24x Premium Survive a Slowing Housing Market?
With shares up just 3% YTD and a premium valuation, HD's Aug. 18 earnings will test whether the market's optimism is justified.
P&G: The 70-Year Dividend King Just Got Cheaper — Time to Buy the Dip?
With shares down near 52-week lows and a 3% yield backed by 70 straight years of dividend hikes, Procter & Gamble is the defensive play for a market that's starting to wobble.